Search For a Provider Facebook Twitter Instagram YouTube ES View the Patient Toolkit


Latest News on Lybrido

Jun 18, 2013

Premenopausal women with hypoactive sexual desire disorder (HSDD) could find some relief through medication by 2016, if clinical trials are successful.

HSDD is a persistent loss of sex drive that causes a woman distress. It may lead to problems in her relationship as well.

It’s normal for a woman’s libido to have its ups and downs throughout her life. Hormonal changes, stress, and fatigue can all affect sex drive. What makes HSDD different is its constancy. Also, for a diagnosis of HSDD, this loss of sex drive cannot be explained by another medical condition or substance. (For example, low libido can be a side effect of certain antidepressants.)

Currently, no medical treatment for HSDD has been approved by the U.S. Food and Drug Administration (FDA). However, researchers at a Dutch company called Emotional Brain hope that their drugs – Lybrido and Lybridos – will eventually be approved and available.


1 2 Next » (page 1 of 2)